Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer. This statement is based on a phase III multicenter, randomized clinical trial that lacks a description of...

Descripción completa

Detalles Bibliográficos
Autores principales: Segura-Sampedro, Juan José, Morales-Soriano, Rafael, Arjona-Sánchez, Álvaro, Cascales-Campos, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216587/
https://www.ncbi.nlm.nih.gov/pubmed/32393274
http://dx.doi.org/10.1186/s12957-020-01853-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216587/
https://www.ncbi.nlm.nih.gov/pubmed/32393274
http://dx.doi.org/10.1186/s12957-020-01853-4

Ejemplares similares